These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. SYMPOSIUM ON LIFE INSURANCE ASPECTS OF CARDIOVASCULAR DISEASE. INTRODUCTION. ORACULAR HEART DISEASE. GUBNER RS Am J Cardiol; 1964 May; 13():573-5. PubMed ID: 14156024 [No Abstract] [Full Text] [Related]
4. [Life insurance medicine: insurance for risk of dying]. Bosch E Ned Tijdschr Geneeskd; 1993 Nov; 137(45):2306-10. PubMed ID: 8255336 [No Abstract] [Full Text] [Related]
5. [Probability statistic methods in life insurance medicine]. Immich H Lebensversicher Med; 1970 Mar; 22(2):35-9. PubMed ID: 4392329 [No Abstract] [Full Text] [Related]
6. Life expectancy and insurability in heart disease. GUBNER RS; UNGERLEIDER HE Mod Concepts Cardiovasc Dis; 1959 Dec; 28():565-9. PubMed ID: 13829982 [No Abstract] [Full Text] [Related]
7. [Greater life expectancy: effect on life insurance]. Bartel H Versicherungsmedizin; 2005 Mar; 57(1):1-2. PubMed ID: 15759806 [No Abstract] [Full Text] [Related]
8. [Insurance related medical aspects of angina pectoris]. Grond A Versicherungsmedizin; 1990 Dec; 42(6):170-4. PubMed ID: 2291267 [TBL] [Abstract][Full Text] [Related]
9. Underwriting the elderly life insurance applicant. Hankwitz PE Med Sect Proc; 1995; ():79-93. PubMed ID: 8677255 [No Abstract] [Full Text] [Related]
10. [Aspects of life expectancy in Down's syndrome with reference to annuity]. Kraus HK Versicherungsmedizin; 1995 Jun; 47(3):102. PubMed ID: 7610525 [No Abstract] [Full Text] [Related]
11. Genetic information and life insurance risk classification and antiselection (1). Pokorski RJ J Insur Med; 1994-1995 Winter; 26(4):413-9. PubMed ID: 10150806 [No Abstract] [Full Text] [Related]
12. [Duration of the human life, its influence on the life insurance and prevention of aging]. GOFFIN J Acta Med Scand Suppl; 1953; 277():381-90. PubMed ID: 13065049 [No Abstract] [Full Text] [Related]
13. [Duration of the human life, its influence on the life insurance and prevention of aging]. VOUTE PA Acta Med Scand Suppl; 1953; 277():269-91. PubMed ID: 13065046 [No Abstract] [Full Text] [Related]
14. [Duration of the human life; its influence on the life insurance and prevention of aging]. FIANDACA S Acta Med Scand Suppl; 1953; 277():292-373. PubMed ID: 13065047 [No Abstract] [Full Text] [Related]
15. [The present duration of the human life; its influence on the life insurance and prevention of premature aging]. KAUFMANN F Acta Med Scand Suppl; 1953; 277():374-80. PubMed ID: 13065048 [No Abstract] [Full Text] [Related]
16. [Prognosis of refused applicants for life insurance]. Stockmann H Lebensversicher Med; 1971 Jul; 23(4):78-84. PubMed ID: 4398052 [No Abstract] [Full Text] [Related]
17. Life insurance: mortality trends and profitable business. Roberts NK J Insur Med; 1998; 30(4):217-9. PubMed ID: 10537925 [No Abstract] [Full Text] [Related]
18. [Multiple sclerosis and its prognostic evaluation in life insurance]. Raestrup O Med Welt; 1967 Apr; 17():1075-81. PubMed ID: 5584465 [No Abstract] [Full Text] [Related]
19. [Medical risk assessment in life insurance of applicants following coronary angioplasty]. Genser N Versicherungsmedizin; 1990 Dec; 42(6):174-8. PubMed ID: 2291268 [TBL] [Abstract][Full Text] [Related]
20. [Coronary heart disease. Prognostic indicators and life expectancy as determining factors of insurability]. Gubner RS Versicherungsmedizin; 1988 Jan; 40(1):2-10. PubMed ID: 3284156 [No Abstract] [Full Text] [Related] [Next] [New Search]